Amgen (AMGN) Announces Plan to Make All Repatha Device Options Available In US at 60 Percent Reduced List Price
Tweet Send to a Friend
Amgen (NASDAQ: AMGN) today announced that as part of the Company's commitment to improve patient affordability for an innovative ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
